SeaStar Medical Holding (ICU) Net Equity Issued and Repurchased (2021 - 2026)
SeaStar Medical Holding's (ICU) quarterly Net Equity Issued and Repurchased came in at $329000.0 in Q1 2026, down 94.02% YoY from $5.5 million in Q1 2025, and down 81.61% on a QoQ basis from $1.8 million in Q4 2025.
SeaStar Medical Holding (ICU) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $329000.0 in Q1 2026.
- Quarterly Net Equity Issued and Repurchased fell 94.02% year-over-year to $329000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.5 million (up 210.11% YoY) and the FY2025 annual result came in at $16.1 million, down 7.54% from the prior year.
- Net Equity Issued and Repurchased retreated to $329000.0 in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $8.6 million in Q3 2025 to a low of -$51000.0 in Q2 2024.
- A 4-year average of $2.5 million and a median of $1.1 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased slumped 192.73% — and 2025, when it jumped 13433.33%.
- Tracing ICU's Net Equity Issued and Repurchased over 4 years: stood at $3.5 million in 2023, then slumped by 97.11% to $100000.0 in 2024, then jumped by 1689.0% to $1.8 million in 2025, then plunged by 81.61% to $329000.0 in 2026.
- The last three Net Equity Issued and Repurchased figures came in at $329000.0 (Q1 2026), $1.8 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 810,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 810,000.00 |
| Jun 30, 2026 | 810,000.00 |
| Mar 31, 2026 | 329,000.00 |
| Mar 31, 2026 | 329,000.00 |
| Dec 31, 2025 | 1.79 Mn |
| Dec 31, 2025 | 1.79 Mn |
| Sep 30, 2025 | 8.60 Mn |
| Sep 30, 2025 | 8.60 Mn |
| Jun 30, 2025 | 6.80 Mn |
| Jun 30, 2025 | 6.80 Mn |
| Mar 31, 2025 | 5.50 Mn |
| Mar 31, 2025 | 5.50 Mn |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | -51,000.00 |
| Jun 30, 2024 | -51,000.00 |
| Mar 31, 2024 | 4.54 Mn |
| Mar 31, 2024 | 4.54 Mn |